Hospitals Are Adding Billions in ‘Facility’ Fees for Routine Care
Unsuspecting patients are finding themselves at the mercy of institutions tacking on the bills.
Unsuspecting patients are finding themselves at the mercy of institutions tacking on the bills.
The OncoAlert Newsletter is now out for June 23-29, 2023
Allogeneic stem cell transplantation (ASCT) from a haploidentical relative may significantly increase the rate of success in Hispanic patients with ALL, according to a recent…
Repotrectinib has been approved by China’s National Medical Products Administration for the treatment of patients with ROS1-positive NSCLC.
In a phase 1/2 trial of NT219 with cetuximab in patients with squamous cell carcinoma of the head and neck, safety and tolerability responses were…
Thomas Coats, PhD, Royal Devon University Hospital Foundation Trust, Exeter, UK, discusses the future of artificial intelligence (AI) models in the field of hematology. Using…
AbstractBackground. Few studies have evaluated mental health disorders comprehensively among patients with prostate cancer on long-term follow-up. The prim
Experiencing guilt after cancer treatment may sound unexpected, but it’s actually quite common. Clinical psychologist Catherine Powers, Ph.D., and senior social work counselor Kendolyn Shankle…
Jubilee Brown, MD, highlights the RAS/MAPK pathway in low-grade serous ovarian cancer and research with avutometinib/defactinib that prompted RAMP 301.
A recent study may have uncovered sex-based disparities in the detection and survival of melanoma in Black patients.
An abstract is unavailable.